Clinical Trial

LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

Name: LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement — clinical trial record (NCT07733076)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

Single center, single arm study to evaluate the Safety and Efficacy of LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement

Trial Details

NCT Number	NCT07733076
Lead Sponsor	Shanghai Zhongshan Hospital Collaborators: Humatrix Medical Technology (Suzhou) Co., LTD
Conditions	Peripheral Arterial Disease
Enrollment	15 participants
Start Date	2026-09-30
Primary Completion	2027-09-30 (estimated)
Study Completion	2028-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-30